Close Menu

    Subscribe to Updates

    Get the latest information from JBUON.

    What's Hot

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025
    Facebook X (Twitter) Instagram
    JBUONJBUON
    • How to Submit
    • Author Guidelines
    Facebook X (Twitter) Instagram
    SUBMIT
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Archives
    • About Journal
      • Journal Information
      • Editorial Board
      • Bibliographic Listings
      • Editorial Policy
      • Ethics and Malpractice Statement
    • For Authors
      • How To Submit
      • Submit Article
      • Downloads
    • Contact
    JBUONJBUON
    Home»Issues»Volume 26, Issue 6»Microsatellite instability in oral squamous cell carcinoma
    Volume 26, Issue 6

    Microsatellite instability in oral squamous cell carcinoma

    November 30, 2021Updated:April 29, 20243 Mins Read
    Share
    Facebook Twitter Email

    Efthymios Kyrodimos1, Aristeidis Chrysovergis1, Evangelos Tsiambas2, Vasileios S Papanikolaou1

    11st ENT Department, Hippocration Hospital, University of Athens, Athens, Greece;

    2Department of Pathology-Cytology, 401 GAH, Athens, Greece

    Abstract

    Dear Editor,

    Microsatellites are referred to repetitive nucleotide sequences including usually 1 to 5 base pairs repeated for 15- 30 times which are normally relatively stable. Thousands of microsatellites are detectable throughout the human genome. In fact, during DNA replication accumulation of them forms a small loop in any of two strands. Insertion or deletion of these repeated nucleotide chains are identified also inside the introns of the genes. For all these molecular reasons, Microsatellite instability (MSI) is a biomarker for detecting DNA MMR deficiency in CRCs and also in a variety of malignancies of different histogenetic origin [1]. Among the genetic mechanisms that provide a stable micro-environment inside the molecule, DNA mismatch repair system (DNA MMR) plays a leading role. Humanized homologues of DNA MMR main genes are located on chromosomes 2, 3, 5 and 7 including MLH1, MSH2, MSH3, GTBP/MSH6, PMS1 and PMS2 [2]. Specific genomic alterations –germline mutations, accompanied usually by allelic loss (loss of heterozygosity -LOH), or epigenetic changes such as promoter hypermethylation- in the MMR genes lead to loss of their expression affecting their function in repairing the corresponding base to base errors. In contrast to colon adenocarcinoma, there are limited data regarding DNA MMR and MSI in oral cavity carcinomas. Two independent study groups were based on patients with different ethnicity (Korean vs Asian Indians) exploring specific genetic polymorphism of the hMLH1gene. They reported that hypermethylation of the hMLH1 gene may be the principal inactivating mechanism in oral cancer with MSI in HPV related lesions and also that the hMLH1 -93 A>G polymorphism is associated with the higher risk of tobacco-related OSCC could be useful in screening population at a higher risk [3,4]. Hypermethylation of hMLH1 and hMSH2 might play a role in oral carcinogenesis and may be correlated with a tendency to develop multiple oral malignancies. Furthermore, expression of hMLH1, hPMS2, and hMSH2 genes seem to be related progressively with oral epithelial dysplasia and squamous cell carcinoma. Immunohistochemical analyses showed that reduced expression of these markers was correlated with dysplasia to carcinoma progression and also with the grade of the carcinomas (poorly differentiated from well-differentiated) [5]. Identification of specific gene deregulation mechanisms regarding DNA MMR genes is a significant issue for understanding their altered protein expression. Reduced expression levels of these markers are correlated with MSI both in oral cavity carcinomas. hMLH1 is a crucial gene for both of them and its abnormal expression and function influences the progression and the biological behavior in these malignancies.

    Full Text: PDF

    Letter to the Editor
    Previous ArticleIsolated contralateral axillary lymph node recurrence in breast cancer
    Next Article Triple negative apocrine breast cancer with atypical metastatic presentations

    Related Articles

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    Volume 26, Issue 6

    Induction chemotherapy in head and neck cancers – old actors, new horizons

    Volume 26, Issue 6

    Caspases-related apoptosis in meningiomas

    Volume 26, Issue 6
    Don't Miss
    Volume 27, 2024

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Dimosthenis Chrysikos1, Spiros Delis2, Charina Triantopoulou2, Evgenia Charitaki2, Nikos Kokoroskos2, Nikolaos Taprantzis1*, Amir Shihada1, Konstantinos…

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025

    Abdominal Aortic Aneurysm and Radiation Therapy

    October 28, 2024
    Our Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021

    Subscribe to Updates

    About Us
    About Us

    Journal of BUON (Print ISSN: 1107-0625, Electronic ISSN: 2241-6293) is an independent Open Access Journal, published by BAKIS Productions LTD, and appears exclusively on the internet. It is covered/indexed in Current Awareness in Biological Sciences (BIO-BASE), EMBASE/Excerpta Medica.
    We're accepting new manuscripts right now.

    Email Us: editorial_office@jbuon.com
    Contact: Available soon

    Editorial Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021
    Get in Touch

    Editor-in-Chief
    Athanasios E. Athanasiou,
    Department of Medical Oncology,
    Metaxa Cancer Hospital, Botassi 51, 18537, Piraeus, Greece
    Editorial Office: editorial_office@jbuon.com

    Publishing support
    EManuscript Technologies
    # 9, First Floor, Vinnse Towers
    Wheeler Road Extension, St. Thomas Town, Bangalore 560 084, INDIA
    E: journals@emanuscript.in 
    W : www.emanuscript.in

     

    • Home
    • Author Guidelines
    • Site Map
    • Contact Us
    © 2025 JBUON Powered by EManuscript.

    Type above and press Enter to search. Press Esc to cancel.